Common Contracts

Contract

August 11th, 2017

• Filed
  August 11th, 2017

CLINICAL TRIAL AGREEMENT FOR PROTOCOL GS-US-419-3895 SMLOUVA O KLINICKÉ STUDII PRO PROTOKOL GS-US-419-3895 This Clinical Trial Agreement (“Agreement”) is entered into as of 26/06/2017 (the “Effective Date”) by and among Thomayerova Nemocnice, a hospital with an address at Vídeňská 800, 140 59 Praha 4, Czech Republic, ID: 00064190, TIN: CZ 00064190, statecontributory organization established by the Ministry of Health of the Czech Republic, full text of foundation deed No. MZDR 17268-IV/2012 represented by doc. MUDr. Zdeněk Beneš, director (the “Institution”), doc. MUDr. Pavel Kohout, PhD., with work address at Thomayerova Nemocnice, Internal Department, pavilon B3, Vídeňská 800, 140 59 Praha 4, Czech Republic the investigator for the Trial (the “Investigator”) and Gilead Sciences, Inc., a Delaware corporation with headquarters located at 333 Lakeside Drive, Foster City, California, 94404, U.S.A. (together with its affiliates and subsidiaries, “Gilead”), in connection with a clinical